REVERSIBLE CELL-DAMAGE BY T-CELL PERFORINS - CALCIUM INFLUX AND PROPIDIUM IODIDE UPTAKE INTO K562 CELLS IN THE ABSENCE OF LYSIS

被引:36
作者
JONES, J
HALLETT, MB
MORGAN, BP
机构
[1] UNIV COLL CARDIFF,DEPT MED BIOCHEM,HEATH PK,CARDIFF CF4 4XN,S GLAM,WALES
[2] UNIV COLL CARDIFF,DEPT SURG,CARDIFF CF4 4XN,S GLAM,WALES
基金
英国惠康基金;
关键词
D O I
10.1042/bj2670303
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The non-lethal effects of the lymphocyte-derived pore-forming toxin perforin on the human erythroleukaemia cell line K562 were investigated. By using the fluorescent Ca2+ indicator fura-2, perforin was shown to cause intracellular Ca2+ concentration to rise transiently into the micromolar range in the absence of cell death. By fluorescence-activated cell sorting it was demonstrated that K562 cells took up the membrane-impermeant nuclear stain propidium iodide (PI) when exposed to non-lethal doses of perforin. The permeability to PI was short-lived, confirming the transience of the perforin pore. Analogies with non-lethal effects and recovery processes occurring in nucleated cells exposed to the membrane-attack complex of complement are drawn.
引用
收藏
页码:303 / 307
页数:5
相关论文
共 18 条
[1]   CALCIUM-ION CONCENTRATIONS AND DNA FRAGMENTATION IN TARGET-CELL DESTRUCTION BY MURINE CLONED CYTO-TOXIC LYMPHOCYTES-T [J].
ALLBRITTON, NL ;
VERRET, CR ;
WOLLEY, RC ;
EISEN, HN .
JOURNAL OF EXPERIMENTAL MEDICINE, 1988, 167 (02) :514-527
[2]   THE USE OF FURA-2 TO DETERMINE THE RELATIONSHIP BETWEEN CYTOPLASMIC FREE CA-2+ AND OXIDASE ACTIVATION IN RAT NEUTROPHILS [J].
ALMOHANNA, FA ;
HALLETT, MB .
CELL CALCIUM, 1988, 9 (01) :17-26
[3]  
BASHFORD CL, 1988, J IMMUNOL, V141, P3965
[4]   DIRECT MEASUREMENT OF THE INCREASE IN INTRACELLULAR FREE CALCIUM-ION CONCENTRATION IN RESPONSE TO THE ACTION OF COMPLEMENT [J].
CAMPBELL, AK ;
DAW, RA ;
HALLETT, MB ;
LUZIO, JP .
BIOCHEMICAL JOURNAL, 1981, 194 (02) :551-560
[5]   MONOCLONAL-ANTIBODIES DEMONSTRATE PROTECTION OF POLYMORPHONUCLEAR LEUKOCYTES AGAINST COMPLEMENT ATTACK [J].
CAMPBELL, AK ;
MORGAN, BP .
NATURE, 1985, 317 (6033) :164-166
[6]  
CARNEY DF, 1985, J IMMUNOL, V134, P1804
[7]  
CARNEY DF, 1986, J IMMUNOL, V137, P263
[8]  
HALLETT MB, 1981, IMMUNOLOGY, V44, P569
[9]  
MORGAN BP, 1987, J IMMUNOL, V138, P246
[10]  
MORGAN BP, 1989, BIOCHEM J, V264, P1